Ethanolic extract of propolis exerts a strong anti-bacterial activity, in addition to antifungal. antiviral and antiprotozoal properties. In previous studies from these laboratories we have demonstrated that the intensity of the bactericidal activity of E E P is correlated with the virulence of the mycobacteria tested, and that E E P has a synergistic effect with antibiotics on growth of staphylococcus aureus. In the present study we investigated whether the same synergism and correlation exists between E E P and some anti-tuberculosis drugs on tubercu losis mycobacteria with different degrees of virulence. Six standard strains and 11 wild strains of mycobacteria were exposed for 30 days to EEP, with or without streptomycin, rifamycin, isoniazid or ethambutol. Out of the 17 strains, 8 were resistant to at least two standard antibiotics, and were considered "multi-resistant strains". The rest were either susceptible or resistant to only one of the antimycobacterial drugs. Antagonism was recorded only in one case, when Staphylococcus aureus were treated with a mixture of E E P and ethambutol, sug gesting that a chemical bond could have been formed between this anti-tuberculosis anti biotic and one of the active components of the ethanol extract of propolis.
Introduction
Propolis is a natural resinous material, gathered and produced by honeybees, and used by them in order to protect their nests against intruders, such as bacteria and insects. It also helps them isolate and disinfect the nests. The ethanolic extract of propolis (E E P ) exerts antibacterial, antifungal, antiviral and antiprotozoal activities, as well as the following properties: antioxidant, free radical scavenger, anticarcinogenic, immunostimulatory, radioprotective and ability to heal damaged tissues (Frankiewicz and Scheller, 1984; Grange and Davey, 1990; Matsuno, 1995; Scheller et al., 1968 Scheller et al., , 1977a Scheller et al., ,b,c, 1978 Scheller et al., , 1988 Scheller et al., , 1989a Scheller et al., ,b,c, 1990 Scheller et al., , 1997 Scheller et al., , 1998 Starzyk et al., 1977) . E E P is rich in various flavonoid aglycones, phenolic compounds, sesquiterpens, diterpens, ste roids, amino acids, carboxyl-acids, aromatic alco hols and about 30 inorganic-, including trace-ele-* * Affiliated with the David R. Bloom Center for Phar macy at the Hebrew University. The majority of the chemical compounds in the ethanolic extract of propolis are strong hydropho bic entities, with high affinity towards lipids. As lipids are the most abundant and distinct in the outer cell surface of mycobacteria, they easily bind such components. In previous studies we have de monstrated that the intensity of the bactericidal activity of E E P is correlated with the virulence of the m ycobacteria, and that when such virulence is augmented, the antimycobacterial activity of E E P is significantly increased (Scheller et al., 1968 (Scheller et al., , 1998 .
Also, in a previous study from our laboratories we have shown that E E P has a synergistic effect with antibiotics on the growth of staphylococcus aureus (Krol et al., 1993) . We decided, therefore, to investigate whether the same synergism and correlation exists between E E P and some anti tuberculosis drugs on tuberculosis mycobacteria that possess different degrees of virulence. 
Materials and Methods

Mycobacteria and their inoculation
Propolis and E E P
Propolis was collected manually in the beehive of the University's farm (bees using mainly Populus buds), and was kept desiccated pending pro cessing. It was extracted in 95% v/v ethanol, in a 1:10 ratio, in hermetically-closed glass vessel, for 10 days at 37 °C, under frequent shaking. The ethanolic extract was then filtered through a W hat man #4 filter paper, and evaporated under vac uum. The dark-brown material (E E P ; yield 4 5 -60% of the raw material) was dissolved in the m e dium prior to its use. The medium containing vari ous concentrations of E E P was coagulated three times, on three consecutive days, at 75 °C.
Antimycobacterial drugs
The following four basic antimycobacterial drugs were used in this study: streptomycin, rifamycin, isoniazid and ethambutol. Each of these drugs was introduced in the Löwenstein-Jensen solid medium in the following concentrations: 
Susceptibility o f mycobacteria to antibiotics
Mycobacteria were inoculated on the solid m e dium containing antibiotics at a concentration of 5 x l 0 -5 bacteria per test-tube and at 37 °C. Growth rate was recorded once weekly, and the final reading was performed on the 30th day after inoculation. Mycobacteria that would not grow in E E P concentrations of 1,800 j.ig/ml and lower, were designated as "susceptible to E E P " and marked "S". Mycobacteria that managed to grow in E E P concentrations of 1,800 ^g/ml and higher, were designated as "resistant to E E P " and marked "R ". A strain was considered resistant ( "R ") if 1% of the mycobacteria would be resistant to 4 [ig/ml streptomycin, 0.2 j-ig/ml isoniazid, 40 [ig/ml rifamy cin or 2.0 |.ig/ml ethambutol.
Results
Out of the 17 strains of mycobacteria that were investigated in this study, eight were resistant to at least two standard antibiotics. Six wild (M. 208, M. 260, M .241, M. 252, M. 323, M. 333) and two standard strains of mycobacteria (H 37Ra and M. intracellulare) and were considered as "multiresistant strains". The rest of the mycobacteria strains appeared either to be totally susceptible or resistant to only one of the investigated antimyco bacterial drugs. E E P partially inhibited the growth rate of 14 out of the 17 mycobacterial strains tested, as could easily be observed by a significant decrease in the size and number of their colonies. Six of the m yco bacterial strains reached the ultimate goal of susceptibility to EEP, when less than 10% of them were resistant to an E E P concentration of 1,800 fig/ml or lower. Some wild strains (one of them originating from a patient that had not been treated with anti-mycobacterial drugs) and one Table I) .
Addition of E E P to medium containing anti-tuberculosis drugs markedly potentiated, in some of the strains, the anti-mycobacterial activity of some of the drugs. Enhanced sensitivity of mycobacteria to their antibiotic treatm ent was observed in 12 of the mycobacterial strains, even if an initial resis tance to some of these antibiotics was recorded during the first weeks of their exposure. In only one strain (M. H 37Rv) an antagonism between the antibacterial activity of E E P and the bacteriostatic efficacy of etambuthol was noticed. The synergism between E E P and some anti-tuberculosis drugs is clearly demonstrated in Table II .
Discussion
Ethanolic extract of propolis is a natural mix ture of a variety of chemical components, with multi-directional properties, including antibacte rial activity. The present study demonstrates po tentiation of the antibacterial property of E E P ex erted on 14 mycobacterial strains out of the 17 strains tested, when such activity (as evaluated by a diminution in the number of bacterial colonies) was recorded only in a single bacterial strain.
The synergistic effect of E E P was demonstrated in the present study with different bactericidal anti-tuberculosis drugs, including streptomycin, rifamycin and isoniazide. No synergism was re corded when the m yco-bacteriostatic agent etambuthol was mixed with EEP. We consider this find ing as an exception rather than the rule in our synergism studies between E E P and established antibacterial agents, and it may be explained by a chemical bond that occurs between etambuthol and one of the E E P components, thus diminishing the active level of etambuthol in the medium (Danysz and Jeljaszewicz, 1976 ).
